|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2011-4-19
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
West Nile virus (WNV) is a flavivirus that causes meningitis and encephalitis. There are no licensed vaccines to prevent WNV in humans. The safety and immunogenicity of a first-generation WNV DNA vaccine was demonstrated in a clinical trial and a similar DNA vaccine has been licensed for use in horses.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1537-6613
|
|
pubmed:author |
pubmed-author:BailerRobert TRT,
pubmed-author:BundrantNikkidaN,
pubmed-author:DesaiNirajN,
pubmed-author:EnamaMary EME,
pubmed-author:GordonIngelise JIJ,
pubmed-author:GrahamBarney SBS,
pubmed-author:GuWenjuanW,
pubmed-author:HubkaSarah ASA,
pubmed-author:KoupRichard ARA,
pubmed-author:LedgerwoodJulie EJE,
pubmed-author:MascolaJohn RJR,
pubmed-author:NabelGary JGJ,
pubmed-author:NasonMarthaM,
pubmed-author:NelsonSteevensonS,
pubmed-author:PiersonTheodore CTC,
pubmed-author:RuckerSteveS,
pubmed-author:VRC 303 Study Team
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
203
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1396-404
|
|
pubmed:meshHeading |
pubmed-meshheading:21398392-Adult,
pubmed-meshheading:21398392-Age Distribution,
pubmed-meshheading:21398392-Aged,
pubmed-meshheading:21398392-Antibodies, Neutralizing,
pubmed-meshheading:21398392-Antibodies, Viral,
pubmed-meshheading:21398392-Female,
pubmed-meshheading:21398392-Humans,
pubmed-meshheading:21398392-Male,
pubmed-meshheading:21398392-Middle Aged,
pubmed-meshheading:21398392-T-Lymphocytes,
pubmed-meshheading:21398392-Vaccines, DNA,
pubmed-meshheading:21398392-Viral Vaccines,
pubmed-meshheading:21398392-West Nile Fever,
pubmed-meshheading:21398392-West Nile virus,
pubmed-meshheading:21398392-Young Adult
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial.
|
|
pubmed:affiliation |
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA. ledgerwood@mail.nih.gov
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase I,
Research Support, N.I.H., Intramural
|
